A Randomized, Triple-Blind, Placebo-Controlled, Add-On Clinical Trial to Evaluate the Efficacy of Emblica officinalis in Uncontrolled Hypertension

Table 2

Blood pressure and heart rate in each group during the study.

Time	Systolic blood pressure			Diastolic blood pressure
	EO	Placebo		EO	Placebo
	Mean (±SD)	Mean (±SD)		Mean (±SD)	Mean (±SD)
Baseline	152.7 (9.5)	146 (8.23)	0.001	93 (7.6)	91.4 (7)	0.31
Week 2	141.2 (15.3)	138.3 (13.8)	0.55	83.4 (8.5)	83.7 (9.6)	0.92
Week 4	133 (13.7)	139.1 (12.8)	0.17	82.1 (5.2)	85.8 (8.2)	0.11
Week 6	134.4 (15.8)	142.5 (11.5)	0.08	79.6 (8.2)	89.5 (8.8)	0.001
Week 8	126.7 (13.8)	136.7 (12.8)	0.009	81.2 (6.3)	87.6 (7.6)	<0.001

EO: Emblica officinalis; SD: standard deviation. t-test.